Skip to main content

Advertisement

Log in

Evaluation of myocardial perfusion and function by gated SPECT in patients with Behçet’s disease

  • Original Article
  • Published:
Annals of Nuclear Medicine Aims and scope Submit manuscript

Abstract

Background

Behçet’s disease (BD) is a systemic multi-system vasculitis that can have a wide range of effects on the cardiovascular system.

Objective

To determine the existence of myocardial perfusion defects caused by coronary microvascular dysfunction in BD and to evaluate coronary arterial distribution and left ventricular systolic function by gated single-photon emission computed tomography (SPECT).

Methods

The study population consisted of 23 (15 men and 8 women) patients with BD and 20 healthy controls (12 men and 8 women). Technetium-99m methoxyisobutylisonitrile (Tc-99m MIBI) gated SPECT studies were performed at stress and rest in a 2-day protocol. Stress and rest left ventricular ejection fraction (LVEF) were calculated. Using non-gated SPECT images myocardial perfusion scores [summed stress score (SSS), summed rest score (SRS), summed difference score (SDS), and fix defect score (FDS)] and perfusion defect extent as percentage (stress, rest ischemic, and fix %LV) were determined. Using gated SPECT images, wall motion score indices (stress wall motion score indices and rest wall motion score indices) were calculated. Coronary angiography (CAG) was applied to patients with abnormal myocardial perfusion scintigraphy (MPS).

Results

The mean ages of the BD and control groups were 39.3 ± 10.6 years and 36.2 ± 8.3 years, respectively. No statistically significant differences were observed between the two groups regarding clinical features and cardiologic findings. Abnormal MPS was found in 13 (56.5%) of the BD patients; 3 patients had non-transmural infarcts and 10 patients reversible perfusion defects. Reversible perfusion defects were also found in two controls (10.0%). When the two groups were compared regarding the gated SPECT findings, differences were determined in the following parameters; SSS, SRS, SDS, FDS, stress and rest LVEF, stress and rest %LV, and stress and rest WMSI. In the BD group, when gated SPECT results were compared between those with and without abnormal MPS, differences were determined in SSS, SRS, SDS, FDS, stress and rest %LV, and stress and rest WMSI. Epicardial coronary arteries were normal in CAG.

Conclusions

Myocardial perfusion and function are disturbed owing to influenced coronary microvascularity in BD, and CAG is frequently observed to be normal. Gated SPECT is a non-invasive reliable method that simultaneously evaluates the existence, extent and severity of myocardial ischemia or infarction and the wall movements in cardio-Behçet.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Marshall SE. Behçet’s disease. Best Pract Res Clin Rheumatol 2004;18:291–311.

    PubMed  CAS  Google Scholar 

  2. International Study Group for Behçet’s Disease. Criteria for diagnosis of Behçet’s disease. Lancet 1990;335:1078–1080.

    Google Scholar 

  3. Yazıcı H, Yurdakul S, Hamuryudan V. Behçet’s syndrome. In: Klippel JH, Dieppe PA, editors. Rheumatology. vol. 2. London: Mosby; 1998. p. 1–6.

    Google Scholar 

  4. Baykan M, Celik S, Erdöl C, Baykan EC, Durmus I, Bahadir S, et al. Behçet’s disease with a large intracardiac thrombus: a case report. Heart 2001;85:e7.

    Article  PubMed  CAS  Google Scholar 

  5. Gullu IH, Benekli M, Muderrisoglu H, Oto A, Kansu E, Kabakcı G, et al. Silent myocardial ischemia in Behçet’s disease. J Rheumatol 1996;23:323–327.

    PubMed  CAS  Google Scholar 

  6. Chajek T, Fainaru M. Behçet’s disease: report of 41 cases and a review of the literature. Medicine 1975;54:179–196.

    Article  PubMed  CAS  Google Scholar 

  7. Gemici K, Baran I, Gullulu S, Kazazoglu AR, Cordan J, Ozer Z. Evaluation of diastolic dysfunction and repolarization dispersion in Behcet’s disease. Int J Cardiol 2000;73:143–148.

    Article  PubMed  CAS  Google Scholar 

  8. Lie JT. Vascular involvement in Behçet’s disease: arterial and venous and vessels of all sizes. J Rheumatol 1992;19:341–343.

    PubMed  CAS  Google Scholar 

  9. James DG, Thomson A. Recognition of the diverse cardiovascular manifestations in Behçet’s disease. Am Heart J 1982;103:457–458.

    Article  PubMed  CAS  Google Scholar 

  10. O’Duffy JD. Vasculitis in Behçet’s disease. Rheumatol Dis Clin North Am 1990;16:423–431.

    CAS  Google Scholar 

  11. Koç Y, Gullu I, Akpek G, Akpolat T, Kansu E, Kiraz S, et al. Vascular involvement in Behçet’s disease. J Rheumatol 1992;19:402–410.

    PubMed  Google Scholar 

  12. Gurgun C, Ercan E, Ceyhan C, Yavuzgil O, Zoghi M, Aksu K, et al. Cardiovascular Involvement in Behçet’s disease. Jpn Heart J 2002;43:389–398.

    Article  PubMed  Google Scholar 

  13. Turkolmez S, Gokcora N, Alkan M, Gürer MA. Evaluation of myocardial perfusion in patients with Behçet’s disease. Ann Nucl Med 2005;19:201–206.

    Article  PubMed  Google Scholar 

  14. Akar H, Konuralp C, Akpolat T. Cardiovascular involvement in Behçet’s disease. Anadolu Kardiyol Derg 2003;3:261–265.

    PubMed  Google Scholar 

  15. Sciagra R, Leoncini M. Gated single-photon emission computed tomography: the present-day “one-stop-shop” for cardiac imaging. Q J Nucl Med Mol Imaging 2005;49:19–29.

    PubMed  CAS  Google Scholar 

  16. Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, et al. A reporting system on patients evaluated for coronary artery disease, report of the ad hoc committee for grading of coronary artery disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975;51:7–34.

    Google Scholar 

  17. Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, et al. Standardized myocardial segmentation and nomenclature for tomographic imaging of the Heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 2002;105:539–542.

    Article  PubMed  Google Scholar 

  18. Jamil G, Ahlberg AW, Elliott MD, Hendel RC, Holly T, McGill CC, et al. Impact of limited treadmill exercise on adenosine Tc-99m sestamibi single photon emission computed tomographic myocardial perfusion imaging in coronary artery disease. Am J Cardiol 1999;84:400–403.

    Article  PubMed  CAS  Google Scholar 

  19. Hachamovitch R, Berman DS, Shaw LJ, Kiat H, Cohen I, Cabico JA, et al. Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death. Circulation 1998;97:535–543.

    PubMed  CAS  Google Scholar 

  20. Levine MG, Ahlberg AW, Mann A, White MP, McGill CC, Mendes de Leon C, et al. Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging. J Nucl Cardiol 1999;6:389–396.

    Article  PubMed  CAS  Google Scholar 

  21. Abidov A, Germano G, Hachamovitch R, Berman DS. Gated SPECT in assessment of regional and global left ventricular function: major tool of modern nuclear imaging. J Nucl Cardiol 2006;13:261–279.

    Article  PubMed  Google Scholar 

  22. Chua T, Kiat H, Germano G, Maurer G, van Train K, Friedman J, et al. Gated technetium-99m sestamibi for simultaneous assessment of stress myocardial perfusion, postexercise regional ventricular function and myocardial viability: correlation with echocardiography and rest thallium-201 scintigraphy. J Am Coll Cardiol 1994;23:1107–1114.

    Article  PubMed  CAS  Google Scholar 

  23. Sakane T, Takeno M, Suzuki N, Inaba G. Behçet’s disease. N Engl J Med 1999;341:1284–1291.

    Article  PubMed  CAS  Google Scholar 

  24. Sismanoglu M, Omeroglu SN, Mansuroglu D, Ardal H, Erentug V, Kaya E, et al. Coronary artery disease and coronary artery bypass grafting in Behçet’s disease. J Card Surg 2005;20:160–163.

    Article  PubMed  Google Scholar 

  25. Huong DL, Wechsler B, Papo T, de Zuttere D, Bletry O, Hernigou A, et al. Endomyocardial fibrosis in Behçet’s disease. Ann Rheum Dis 1997;56:205–208.

    PubMed  CAS  Google Scholar 

  26. Shmitz-Haubner U, Knop J. Evidence for endothelial cell dysfunction in association with Behçet’s disease. Thromb Res 1984;34:277–285.

    Article  Google Scholar 

  27. Gimbrone MA Jr. Vascular endothelium: an integrator of pathophysiologic stimuli in atherosclerosis. Am J Cardiol 1995;75:67B–70B.

    Article  PubMed  CAS  Google Scholar 

  28. Chambers JC, Haskard DO, Kooner JS. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet’s syndrome. J Am Coll Cardiol 2001;37:517–520.

    Article  PubMed  CAS  Google Scholar 

  29. Daou D, Delahaye N, Vilain D, Lebtahi R, Faraggi M, Le Guludec D. Identification of extensive coronary artery disease: incremental value of exercise Tl-201 SPECT to clinical and stress test variables. J Nucl Cardiol 2002;9:161–168.

    Article  PubMed  Google Scholar 

  30. Nallamothu N, Ghods M, Heo J, Iskandrian AS. Comparison of thallium-201 single-photon emission computed tomography and electrocardiographic response during exercise in patients with normal rest electrocardiographic results. J Am Coll Cardiol 1995;25:830–836.

    Article  PubMed  CAS  Google Scholar 

  31. Kosar F, Sahin I, Gullu H, Cehreli S. Acute myocardial infarction with normal coronary arteries in a young man with the Behçet’s disease. Int J Cardiol 2005;99:355–357.

    Article  PubMed  Google Scholar 

  32. Gullu H, Caliskan M, Erdogan D, Yilmaz S, Dursun R, Ciftci O, et al. Impaired coronary microvascular functions in patients with Behçet disease. J Am Coll Cardiol 2006;48:586–587.

    Article  PubMed  Google Scholar 

  33. Melua A, Campbell N, McCluskey D, MacGowan SW. Aorto-atrial fistula without aneurysm formation in Behçet’s disease. Heart 1998;80:200–201.

    PubMed  CAS  Google Scholar 

  34. Ozeren M, Dogan OV, Dogan S, Yucel E. True and pseudo aneurysms of coronary arteries in a patient with Behçet’s disease. Eur J Cardiothorac Surg 2004;25:465–467.

    Article  PubMed  Google Scholar 

  35. Karata K, Onder M, Meray J. Autonomic nervous system involvement in Behçet’s disease. Rheumatol Int 2002;22:155–159.

    Article  Google Scholar 

  36. Hattori S, Kawana S. Behçet’s syndrome associated with acute myocardial infarction. J Nippon Med Sch 2003;70:49–52.

    Article  PubMed  Google Scholar 

  37. Iyisoy A, Kursaklioglu H, Kose S, Yesilova Z, Ozturk C, Saglam K, et al. Acute myocardial infarction and left subclavian artery occlusion in Behçet’s disease. Mt Sinai J Med 2004;71:330–334.

    PubMed  Google Scholar 

  38. Yazici H, Fresko I, Yurdakul S. Behçet’s syndrome: disease manifestations, management, and advances in treatment. Nat Clin Pract Rheumatol 2007;3:148–155.

    Article  PubMed  Google Scholar 

  39. Go V, Bhatt MR, Hendel RC. The diagnostic and prognostic value of ECG-gated SPECT myocardial perfusion imaging. J Nucl Med 2004;45:912–921.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eser Kaya.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kaya, E., Saglam, H., Ciftci, İ. et al. Evaluation of myocardial perfusion and function by gated SPECT in patients with Behçet’s disease. Ann Nucl Med 22, 287–295 (2008). https://doi.org/10.1007/s12149-007-0115-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12149-007-0115-y

Keywords

Navigation